Gujarat Themis Biosyn Ltd (GTHM)

Currency in INR
421.25
+5.40(+1.30%)
Closed·

GTHM Financial Summary

Key Ratios

P/E Ratio92.28
Price/Book16.59
Debt / Equity12.27%
Return on Equity21.69%
Dividend Yield0.16%
EBITDA684.61M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 4.10%
Dividend Yield
0.16%
Industry Median 0.75%
Annualised payout
0.67
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 01, 2025
EPS / Forecast
0.83 / --
Revenue / Forecast
358.73M / --
EPS Revisions
Last 90 days

FAQ

What were Gujarat Themis Biosyn's earnings for the latest quarter?

The Gujarat Themis Biosyn EPS (TTM) is 4.10. Gujarat Themis Biosyn reported sales of 358.73, net income of 90.62, and EPS of 0.83 for the latest quarter.

What was Gujarat Themis Biosyn's net income for the latest quarter?

Gujarat Themis Biosyn's net income for the latest quarter was 90.62.

How did Gujarat Themis Biosyn's performance compare year-over-year in the latest quarter?

The company's revenue moved from 377.36 in the previous quarter to 358.73 in the latest quarter, and net income moved from 119.98 to 90.62 compared to the previous quarter.

What is Gujarat Themis Biosyn's net profit margin on a TTM basis?

Gujarat Themis Biosyn's trailing twelve months (TTM) net profit margin is 32.34%.

How does Gujarat Themis Biosyn's debt to equity ratio compare to industry standards?

Gujarat Themis Biosyn's total debt-to-equity ratio is 12.27%.

What is Gujarat Themis Biosyn's return on investment on a TTM basis?

Gujarat Themis Biosyn's trailing twelve months (TTM) return on investment (ROI) is 21.69%.

How has Gujarat Themis Biosyn's total revenue grown this year?

Gujarat Themis Biosyn's total revenue was 377.36 in the previous quarter and 358.73 in the latest quarter.

What is Gujarat Themis Biosyn's gross margin on a TTM basis?

Gujarat Themis Biosyn's trailing twelve months (TTM) gross margin is 60.60%.

What was Gujarat Themis Biosyn's revenue per share for the latest quarter?

Gujarat Themis Biosyn's revenue per share for the latest quarter was 294.01.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.